Advertisement

Blue Light Therapy

  • Giovanni Cannarozzo
  • Steven Paul Nisticò
  • Keyvan Nouri
  • Mario Sannino
Chapter
  • 87 Downloads

Abstract

The LED blue light (BL) phototherapy, using photo-converter chromophores, provides long-term efficacy and safety in the treatment of acne vulgaris. Treatment with BL turns out to be safe and effective as well as pleasant. The results seem to be long lasting with negligible or completely absent downtime. The only side effects appear to be a fleeting erythema and a bronze effect that, in some cases, could also be aesthetically pleasing.

Notes

Acknowledgment

Special thanks to Dr. Luigi Bennardo and Dr. Giuseppe Lodi for their precious contribution in editing and revising this chapter.

References

  1. 1.
    Garza ZCF, Born M, PAJ H, van Riel NAW, Liebmann J. Visible light therapy: molecular mechanisms and therapeutic opportunities. Curr Med Chem. 2018;25(40):5564–77.CrossRefGoogle Scholar
  2. 2.
    Liebmann J, Born M, Kolb-Bachofen V. Bluelight irradiation regulates proliferation and differentiation in human skin cells. J Invest Dermatol. 2010;130(1):259–69.  https://doi.org/10.1038/jid.2009.194.CrossRefPubMedGoogle Scholar
  3. 3.
    Pfaff S, Liebmann J, Born M, Merk HF, von Felbert V. Prospective randomized long-term study on the efficacy and safety of UV-free blue light for treating mild psoriasis vulgaris. Dermatology. 2015;231(1):24–34.  https://doi.org/10.1159/000430495.CrossRefPubMedGoogle Scholar
  4. 4.
    Ansaripour A, Thio HB, Maessen R, Redekop WK. The cost-effectiveness of blue-light therapy in the treatment of mild-to-moderate psoriasis. J Comp Eff Res. 2017;6(4):325–35.  https://doi.org/10.2217/cer-2017-0007.CrossRefPubMedGoogle Scholar
  5. 5.
    Félix Garza ZC, Liebmann J, Born M, Hilbers PA, van Riel NA. A dynamic model for prediction of psoriasis management by blue light irradiation. Front Physiol. 2017;8(28)  https://doi.org/10.3389/fphys.2017.00028.
  6. 6.
    Falcone D, Uzunbajakava NE, van Abeelen F, Oversluizen G, Peppelman M, van Erp PEJ, van de Kerkhof PCM. Effects of blue light on inflammation and skin barrier recovery following acute perturbation. Pilot study results in healthy human subjects. Photodermatol Photoimmunol Photomed. 2017;34:184.  https://doi.org/10.1111/phpp.12367.CrossRefPubMedGoogle Scholar
  7. 7.
    Opländer C, Deck A, Volkmar CM, Kirsch M, Liebmann J, Born M, van Abeelen F, van Faassen EE, Kröncke KD, Windolf J, Suschek CV. Mechanism and biological relevance of blue-light (420–453 nm)-induced nonenzymatic nitric oxide generation from photolabile nitric oxide derivatives in human skin in vitro and in vivo. Free Radic Biol Med. 2013;65:1363–77.  https://doi.org/10.1016/j.freeradbiomed.2013.09.022.CrossRefPubMedGoogle Scholar
  8. 8.
    Nikolis A, Bernstein S, Kinney B, Scuderi N, Rastogi S, Sampalis JS. A randomized, placebo-controlled, single-blinded, split-faced clinical trial evaluating the efficacy and safety of KLOX-001 gel formulation with KLOX light-emitting diode light on facial rejuvenation. Clin Cosmet Investig Dermatol. 2016;9:115–25.  https://doi.org/10.2147/CCID.S100697.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Wheeland RG, Koreck A. Safety and effectiveness of a new blue light device for the self-treatment of mild-to-moderate acne. J Clin Aesthet Dermatol. 2012;5(5):25–31.PubMedPubMedCentralGoogle Scholar
  10. 10.
    Tzung TY, Wu KH, Huang ML. Blue light phototherapy in the treatment of acne. Photodermatol Photoimmunol Photomed. 2004;20(5):266–9.  https://doi.org/10.1111/j.1600-0781.2004.00109.x.CrossRefPubMedGoogle Scholar
  11. 11.
    Alexiades M. Laser and light-based treatments of acne and acne scarring. Clin Dermatol. 2017;35(2):183–9.  https://doi.org/10.1016/j.clindermatol.2016.10.012.CrossRefPubMedGoogle Scholar
  12. 12.
    Opländer C, Hidding S, Werners FB, Born M, Pallua N, Suschek CV. Effects of blue light irradiation on human dermal fibroblasts. J Photochem Photobiol B. 2011;103(2):118–25.  https://doi.org/10.1016/j.jphotobiol.2011.02.018.CrossRefPubMedGoogle Scholar
  13. 13.
    Cannarozzo G, Sannino M, Tamburi F, Chiricozzi A, Saraceno A, Morini C, Nisticò S. Deep pulse fractional CO2 laser combined with a radio-frequency system: results of a case series. Photomed Laser Surg. 2014;32(7):409–12.  https://doi.org/10.1089/pho.2014.3733.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Filippini M, Del Duca E, Negosanti F, Bonciani D, Negosanti L, Sannino M, Cannarozzo G, Nisticò S. Fractional CO2 laser: from skin rejuvenation to vulvo-vaginal reshaping. Photomed Laser Surg. 2017;35(3):171–5.  https://doi.org/10.1089/pho.2016.4173.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Mercuri SR, Brianti P, Dattola A, Bennardo L, Silvestri M, Schipani G, Nisticò SP. CO2 laser and photodynamic therapy: Study of efficacy in periocular BCC. Dermatol Ther. 2018;31(4):e12616.  https://doi.org/10.1111/dth.12616.CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Weiss RA, Weiss MA, Geronemus RG. McDaniel DH. A novel non-thermal non-ablative full panel LED photomodulation device for reversal of photoaging: digital microscopic and clinical results in various skin types. J Drugs Dermatol. 2004;3(6):605–10.PubMedGoogle Scholar
  17. 17.
    Dai T, Gupta A, Huang YY, Sherwood ME, Murray CK, Vrahas MS, Kielian T, Hamblin MR. Blue light eliminates community-acquired methicillin-resistant Staphylococcus aureus in infected mouse skin abrasions. Photomed Laser Surg. 2013;31(11):531–8.  https://doi.org/10.1089/pho.2012.3365.CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Wang Y, Wu X, Chen J, Amin R, Lu M, Bhayana B, Zhao J, Murray CK, Hamblin MR, Hooper DC, Dai T. Antimicrobial blue light inactivation of Gramnegative pathogens in biofilms: in vitro and in vivo studies. J Infect Dis. 2016;213(9):1380–7.  https://doi.org/10.1093/infdis/jiw070.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Amin RM, Bhayana B, Hamblin MR, Dai T. Antimicrobial blue light inactivation of Pseudomonas aeruginosa by photo-excitation of endogenous porphyrins: in vitro and in vivo studies. Lasers Surg Med. 2016;48(5):562–8.  https://doi.org/10.1002/lsm.22474.CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Dai T, Gupta A, Huang YY, Yin R, Murray CK, Vrahas MS, Sherwood ME, Tegos GP, Hamblin MR. Blue light rescues mice from potentially fatal Pseudomonas aeruginosa burn infection: efficacy, safety, and mechanism of action. Antimicrob Agents Chemother. 2013;57(3):1238–45.  https://doi.org/10.1128/AAC.01652-12.CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Abana CM, Brannon JR, Ebbott RA, Dunigan TL, Guckes KR, Fuseini H, Powers J, Rogers BR, Hadjifrangiskou M. Characterization of blue light irradiation effects on pathogenic and nonpathogenic Escherichia coli. Microbiology. 2017;6:e00466.  https://doi.org/10.1002/mbo3.466.CrossRefGoogle Scholar
  22. 22.
    Bagherani N. Efficacy of blue light in treatment of acne. Dermatol Ther. 2016;29(3):210.  https://doi.org/10.1111/dth.12291.CrossRefPubMedGoogle Scholar
  23. 23.
    Terrell S, Aires D, Schweiger ES. Treatment of acne vulgaris using blue light photodynamic therapy in an African-American patient. J Drugs Dermatol. 2009;8(7):669–71.PubMedGoogle Scholar
  24. 24.
    Antoniou C, Dessinioti C, Sotiriadis D, Kalokasidis K, Kontochristopoulos G, Petridis A, Rigopoulos D, Vezina D, Nikolis A. A multicenter, randomized, split-face clinical trial evaluating the efficacy and safety of chromophore gel-assisted blue light phototherapy for the treatment of acne. Int J Dermatol. 2016;55(12):1321–8.  https://doi.org/10.1111/ijd.13349.CrossRefPubMedGoogle Scholar
  25. 25.
    Nikolis A, Fauverghe S, Scapagnini G, Sotiriadis D, Kontochristopoulos G, Petridis A, Rigopoulos D, Dessinioti C, Kalokasidis K, Antoniou C. An extension of a multicenter, randomized, split-face clinical trial evaluating the efficacy and safety of chromophore gel-assisted blue light phototherapy for the treatment of acne. Int J Dermatol. 2017;57(94)  https://doi.org/10.1111/ijd.13814.CrossRefGoogle Scholar
  26. 26.
    Fan X, Xing YZ, Liu LH, Liu C, Wang DD, Yang RY, Lapidoth M. Effects of 420-nm intense pulsed light in an acne animal model. J Eur Acad Dermatol Venereol. 2013;27(9):1168–71.  https://doi.org/10.1111/j.1468-3083.2012.04487.x.CrossRefPubMedGoogle Scholar
  27. 27.
    Fabbrocini G, Annunziata MC, D’Arco V, De Vita V, Lodi G, Mauriello MC, Pastore F, Monfrecola G. Acne scars: pathogenesis, classification and treatment. Dermatol Res Pract. 2010;2010:893080.  https://doi.org/10.1155/2010/893080.CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Mamalis A, Garcha M, Jagdeo J. Light emitting diode-generated blue light modulates fibrosis characteristics: fibroblast proliferation, migration speed, and reactive oxygen species generation. Lasers Surg Med. 2015;47(2):210–5.  https://doi.org/10.1002/lsm.22293.CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Lee HS, Jung SE, Kim SK, Kim YS, Sohn S, Kim YC. Low-level light therapy with 410 nm light emitting diode suppresses collagen synthesis in human keloid fibroblasts: an in vitro study. Ann Dermatol. 2017;29(2):149–55.  https://doi.org/10.5021/ad.2017.29.2.149.CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Lev-Tov H, Brody N, Siegel D, Jagdeo J. Inhibition of fibroblast proliferation in vitro using low-level infrared light-emitting diodes. Dermatol Surg. 2013;39(3 Pt 1):422–5.  https://doi.org/10.1111/dsu.12087.CrossRefPubMedGoogle Scholar
  31. 31.
    Bauer J, Büttner P, Luther H, Wiecker TS, Möhrle M, Garbe C. Blue light phototherapy of neonatal jaundice does not increase the risk for melanocytic nevus development. Arch Dermatol. 2004;140(4):493–4.  https://doi.org/10.1001/archderm.140.4.493.CrossRefPubMedGoogle Scholar
  32. 32.
    Lai YC, Yew YW. Neonatal blue light phototherapy and melanocytic nevus count in children: a systematic review and meta-analysis of observational studies. Pediatr Dermatol. 2016;33(1):62–8.  https://doi.org/10.1111/pde.12730.CrossRefPubMedGoogle Scholar
  33. 33.
    Kleinpenning MM, Smits T, Frunt MH, van Erp PE, van de Kerkhof PC, Gerritsen RM. Clinical and histological effects of blue light on normal skin. Photodermatol Photoimmunol Photomed. 2010;26(1):16–21.  https://doi.org/10.1111/j.1600-0781.2009.00474.x.CrossRefPubMedGoogle Scholar
  34. 34.
    Nistico S, Tamburi F, Bennardo L, Dastoli S, Schipani G, Caro G, Fortuna MC, Rossi A. Treatment of telogen effluvium using a dietary supplement containing Boswellia serrata, Curcuma longa, and Vitis vinifera: Results of an observational study. Dermatol Ther. 2019;32(3):e12842.  https://doi.org/10.1111/dth.12842.CrossRefGoogle Scholar
  35. 35.
    Muscoli C, Lauro F, Dagostino C, Ilari S, Giancotti LA, Gliozzi M, Costa N, Carresi C, Musolino V, Casale F, Ventrice D, Oliverio E, Palma E, Nisticò S, Procopio A, Mollace V. Olea europea-derived phenolic products attenuate antinociceptive morphine tolerance: an innovative strategic approach to treat cancer pain. J Biol Reg Homeost Ag. 2014;28(1):105–16.Google Scholar
  36. 36.
    Terrinoni A, Codispoti A, Serra V, Bruno E, Didona B, Paradisi M, Nisticò S, Campione E, Napolitano B, Diluvio L, Melino G. Connexin 26 (GJB2) mutations as a cause of the KID syndrome with hearing loss. Biochem Biophys Res Commun. 2010;395(1):25–30.  https://doi.org/10.1016/j.bbrc.2010.03.098.CrossRefPubMedPubMedCentralGoogle Scholar
  37. 37.
    Paolillo N, Piccirilli S, Giardina E, Rispoli V, Colica C, Nisticò S. Effects of paraquat and capsaicin on the expression of genes related to inflammatory, immune responses and cell death in immortalized human HaCat keratinocytes. Int J Immunopathol Pharmacol. 2011;24(4):861–8.  https://doi.org/10.1177/039463201102400405.CrossRefGoogle Scholar
  38. 38.
    Chiricozzi A, Pitocco R, Saraceno R, Giunta A, Nisticò S, Chimenti S. New topical treatments for psoriasis. Exp Op Pharmacother. 2014;15(4):461–70.CrossRefGoogle Scholar
  39. 39.
    Chiricozzi A, Saraceno R, Cannizzaro MV, Nisticò SP, Chimenti S, Giunta A. Complete resolution of erythrodermic psoriasis in a HIV and HCV patient unresponsive to anti-psoriatic treatments after highly active anti-retroviral therapy (ritonavir, atenzanavir, emtricitabine, tenofovir). Dermatology. 2012;225(4):333–7.CrossRefGoogle Scholar
  40. 40.
    Specchio F, Saraceno R, Chimenti S, Nisticò S. Management of non-melanoma skin cancer in solid organ transplant recipients. Int J Immunopathol Pharmacol. 2014;27(1):21–4.  https://doi.org/10.1177/039463201402700104.CrossRefPubMedPubMedCentralGoogle Scholar
  41. 41.
    Specchio F, Carboni I, Chimenti S, Tamburi F, Nisticò S. Cutaneous manifestations in patients with chronic renal failure on hemodialysis. Int J Immunopathol Pharmacol. 2014;27(1):1–4.  https://doi.org/10.1177/039463201402700101.CrossRefPubMedPubMedCentralGoogle Scholar
  42. 42.
    Bottoni U, Tiriolo R, Pullano S, Dastoli S, Amoruso G, Nistico S, Fiorillo A. Infrared saliva analysis of psoriatic and diabetic patients: similarities in protein components. IEEE Trans Biomed Eng. 2016;63(2):379–84.  https://doi.org/10.1109/TBME.2015.2458967.CrossRefPubMedPubMedCentralGoogle Scholar
  43. 43.
    Chimento SM, Newland M, Ricotti C, Nistico S, Romanelli P. A pilot study to determine the safety and efficacy of monochromatic excimer light in the treatment of vitiligo. J Drugs Dermatol. 2008;7(3):258–63.PubMedPubMedCentralGoogle Scholar
  44. 44.
    Nisticò S, Saraceno R, Capriotti E, De Felice C, Chimenti S. Efficacy of monochromatic excimer light (308nm) for the treatment of atopic dermatitis in adults and children. Photomed Laser Surg. 2008;26(1):14–8.  https://doi.org/10.1089/pho.2017.2116.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  • Giovanni Cannarozzo
    • 1
  • Steven Paul Nisticò
    • 2
  • Keyvan Nouri
    • 3
  • Mario Sannino
    • 1
  1. 1.Department of DermatologyUniversity of Rome Tor VergataRomeItaly
  2. 2.Department of Health ScienceMagna Graecia UniversityCatanzaroItaly
  3. 3.Department of Dermatology and Cutaneous SurgeryUniversity of Miami Leonard M. Miller School of MedicineMiamiUSA

Personalised recommendations